Schedule (route) |
Endpoint |
Vehicle |
Dose |
Treated/Control (%) |
Observations |
Q04DX003 (ip) |
median survival time |
suspension in saline |
2.5 mg/kg/injection |
136.0 |
Antitumor endpoint evaluated on day 60; 06/06 animals surviving on day 10 |
Q04DX003 (ip) |
median survival time |
suspension in saline |
5.0 mg/kg/injection |
182.0 |
Antitumor endpoint evaluated on day 60; 06/06 animals surviving on day 10 |
Q04DX003 (ip) |
median survival time |
suspension in saline |
10.0 mg/kg/injection |
203.0 |
Antitumor endpoint evaluated on day 60; 06/06 animals surviving on day 10 |
Q04DX003 (ip) |
median survival time |
suspension in saline |
20.0 mg/kg/injection |
0.0 |
Antitumor endpoint evaluated on day 60; 00/06 animals surviving on day 10 |